25-02-2022 14:00
via
wallstreet-online.de
Karo Pharma Q4 EBIT SEK -52.7 Million
(PLX AI) – Karo Pharma Q4 revenue SEK 762 million.Q4 EPS SEK -0.48
Weiterlesen »